Norepinephrine hypothesis for visual cortical plasticity: thesis, antithesis, and recent development.
Kasamatsu
T
T
Smith-Kettlewell Eye Research Foundation, Pacific Presbyterian Medical Center, San Francisco, California 94115.
D000818:Animals; D000831:Animals, Newborn; D007839:Functional Laterality; D006892:Hydroxydopamines / Q000494:pharmacology; D007031:Hypothalamus / Q000502:physiology; D007276:Injections, Intraventricular; D008125:Locus Coeruleus / Q000187:drug effects / Q000502:physiology; D008954:Models, Biological; D009474:Neurons / Q000502:physiology; D009638:Norepinephrine / Q000502:physiology*; D016627:Oxidopamine; D011943:Receptors, Adrenergic, beta / Q000502:physiology; D014785:Vision, Ocular / Q000502:physiology; D014793:Visual Cortex / Q000187:drug effects / Q000254:growth & development*
D006892:Hydroxydopamines; D011943:Receptors, Adrenergic, beta; D016627:Oxidopamine; D009638:Norepinephrine